Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion type Assertion NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_head.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion description "[To evaluate the effects of dexloxiglumide, a CCK-1 receptor antagonist, on gastrointestinal transit (GIT) and symptoms in patients with constipation-predominant IBS (C-IBS); and to explore the influence of CCK-1 receptor polymorphisms on gut transit and the pharmacodynamic response to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_provenance.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion evidence source_evidence_literature NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_provenance.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion SIO_000772 15743365 NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_provenance.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion wasDerivedFrom gad-20130706 NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_provenance.
- NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_assertion wasGeneratedBy ECO_0000203 NP47487.RA1RZfo9MbaNVA2gxmQ7-W63cEtmDxzg4IEAFBAuu1MXs130_provenance.